Reinventing Supply Chains of Tomorrow

By Kiran Mazumdar-Shaw The aftermath of the COVID-19 pandemic and the ongoing Russia-Ukraine war have triggered massive disruptions in global supply chains, revealing the vulnerability of networks that were largely built on cost optimisation. Supply chains are critical to global growth, so their reinvention is vital to rebuilding economies in the post pandemic world. A … Continue reading Reinventing Supply Chains of Tomorrow

A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw

A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw

Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw

The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League

Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League

Budget: Taking Strides Towards Digital Health

By Kiran Mazumdar-Shaw It was very heartening to see a Budget empathize with those who had to bear adverse health effects of the pandemic. The wide coverage of our nation’s vaccination drive greatly helped amidst the 3rd wave of the pandemic caused by the Omicron variant, resulting in milder symptoms. Even though India is in … Continue reading Budget: Taking Strides Towards Digital Health

A Fair Budget that Balances the Needs of the Indian Economy

By Kiran Mazumdar-Shaw Finance Minister Nirmala Sitharaman has presented the nation with a balanced Budget for FY23. The Indian economy needs a steadying hand at a time when it is trying to find its feet as the tremors from the global COVID-19 pandemic recede slowly. She has prudently laid the groundwork for a gradual economic … Continue reading A Fair Budget that Balances the Needs of the Indian Economy

A Balanced Budget

By Kiran Mazumdar Shaw, Chairperson, Biocon Finance Minister Nirmala Sitharaman has delivered a Budget that ticks several boxes. The Budget focused on maintaining fiscal prudence, improving ease of doing business, boosting infrastructure, and creating a strong digital governance architecture. The economic gloom caused by the Covid-19 pandemic had raised expectations of a ‘feel good’ budget. … Continue reading A Balanced Budget

HOPE FM DELIVERS A FEEL-GOOD BUDGET

By Kiran Mazumdar-Shaw The Covid-19 pandemic has cast a gloomy outlook across the entire economy. Government coffers are depleting, Industry investments are shrinking, and citizens are being hit by inflation and job losses.  Budget 2022 is an event that everyone is hoping will deliver good news and I wish the Finance Minister will not dash our hopes! … Continue reading HOPE FM DELIVERS A FEEL-GOOD BUDGET

Kiran Mazumdar-Shaw’s Statement on John Shaw’s Offshore Trust

Notification to Stock Exchanges October 4, 2021 I would like to explain the situation relating to certain media reports on Pandora Papers which have referred to my husband John Shaw’s Offshore trust. I would like to state that these stories have grossly misrepresented the facts. I would therefore like to present the facts to you … Continue reading Kiran Mazumdar-Shaw’s Statement on John Shaw’s Offshore Trust

$150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector

By Kiran Mazumdar-Shaw In the face of the biggest health calamity faced by humanity in a century, India’s Bioeconomy grew over 12% to reach $70.2 billion in 2020. The biotech industry braved the challenges of Covid-19 to develop innovative solutions such as diagnostics, therapies and vaccines at speed and scale to save countless lives. India … Continue reading $150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector